08 September 2003
Antioxidant and prooxidant properties of caffeine, theobromine and xanthine
Sonish Azam, Naghma Hadi, Nizam Uddin Khan, Sheikh Mumtaz HadiMed Sci Monit 2003; 9(9): BR325-330 :: ID: 13137
Abstract
Background:Caffeine, along with its catabolic products theobromine and xanthine, is a key component of tea and coffee. These compounds are structurally similar to uric acid, a known antioxidant which is present in blood at relatively high concentrations, but also shows prooxidant activity. In view of the structural similarity between uric acid and caffeine and its metabolites, we studied the antioxidant and prooxidant properties of these compounds.Material/Methods:Antioxidant activity was determined by measuring the quenching effect of the compounds on oxidative DNA degradation by a hydroxyl radical generating system. Prooxidant activity was studied by measuring the ability of the compounds to oxidatively degrade DNA in the presence of copper ions.Results:Caffeine, theobromine and xanthine have a quenching effect on the production of hydroxyl radicals, as well as on oxidative DNA breakage by hydroxyl radicals. Consistent with previous observations that many known antioxidants of plant origin are also capable of prooxidant action, the purine alkaloids also show oxidative DNA breakage in the presence of transition metal ions.Conclusions:The alkaloid caffeine and its catabolic products theobromine and xanthine exhibit both antioxidant and prooxidant properties. The results lead to the observation that caffeine and its metabolites may also contribute to the overall antioxidant and chemopreventive properties of caffeine-bearing beverages, such as tea.
Keywords: Antioxidants - chemistry, Antioxidants - pharmacology, Caffeine - chemistry, Caffeine - pharmacology, Cattle, Copper - chemistry, Copper - metabolism, DNA - chemistry, DNA - drug effects, DNA - metabolism, DNA Damage, Hydroxyl Radical - chemistry, Hydroxyl Radical - metabolism, Oxidants - chemistry, Oxidants - pharmacology, Plasmids - drug effects, Plasmids - genetics, Plasmids - metabolism, Theobromine - chemistry, Theobromine - pharmacology, Uric Acid - chemistry, Uric Acid - pharmacology, Xanthine - chemistry, Xanthine - pharmacology
Editorial
01 July 2026 : Editorial
Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development AcceleratesDOI: 10.12659/MSM.954627
Med Sci Monit 2026; 32:e954627
In Press
Review article
Anisodus tanguticus in Cancer Research: A Review of Traditional Use, Phytochemistry, Extraction Methods, an...Med Sci Monit In Press; DOI: 10.12659/MSM.952999
Clinical Research
Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple SclerosisMed Sci Monit In Press; DOI: 10.12659/MSM.952850
Clinical Research
Modified Thoracoabdominal Nerves Block Through the Perichondrial Approach vs Subcostal Transversus Abdomini...Med Sci Monit In Press; DOI: 10.12659/MSM.953976
Clinical Research
Establishment of a Novel Approach for Drug Abuse Monitoring and Its Application in Medical InstitutionsMed Sci Monit In Press; DOI: 10.12659/MSM.952054
Most Viewed Current Articles
17 Jan 2024 : Review article 14,176,599
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,762,852
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,466,335
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 708,939
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






